Benjamin Caulier

  • Postdoc
  • +47 22 78 23 16
 

Publications 2024

Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, García de Jalón E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjørge L, McCormack E, Inderberg EM, Wälchli S (2024)
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
J Immunother Cancer, 12 (4)
DOI 10.1136/jitc-2023-008179, PubMed 38604812

Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S (2024)
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
Cell Rep Med, 101572 (in press)
DOI 10.1016/j.xcrm.2024.101572, PubMed 38754420

Publications 2023

Casey NP, Klee CH, Fåne A, Caulier B, Graczyk-Jarzynka A, Krawczyk M, Fidyt K, Josefsson SE, Köksal H, Dillard P, Patkowska E, Firczuk M, Smeland EB, Winiarska M, Myklebust JH, Inderberg EM, Wälchli S (2023)
Efficient chimeric antigen receptor targeting of a central epitope of CD22
J Biol Chem, 299 (7), 104883
DOI 10.1016/j.jbc.2023.104883, PubMed 37269947

Hannani D, Leplus E, Laurin D, Caulier B, Aspord C, Madelon N, Bourova-Flin E, Brambilla C, Brambilla E, Toffart AC, Laulagnier K, Chaperot L, Plumas J (2023)
A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients
Int J Mol Sci, 24 (3)
DOI 10.3390/ijms24031897, PubMed 36768214

Joaquina S, Forcados C, Caulier B, Inderberg EM, Wälchli S (2023)
Determination of CAR T cell metabolism in an optimized protocol
Front Bioeng Biotechnol, 11, 1207576
DOI 10.3389/fbioe.2023.1207576, PubMed 37409169

Publications 2022

Caulier B, Lenormand JL, Laurin D (2022)
Recombinant Transcription Factors (TFs) Fused to ZEBRA Minimal Transduction Domain (MD) for Modulation of mRNA Transcripts
Methods Mol Biol, 2383, 275-291
DOI 10.1007/978-1-0716-1752-6_19, PubMed 34766297

Forcados C, Joaquina S, Casey NP, Caulier B, Wälchli S (2022)
How CAR T Cells Breathe
Cells, 11 (9)
DOI 10.3390/cells11091454, PubMed 35563759

Publications 2021

Caulier B, Enserink JM, Wälchli S (2021)
Pharmacologic Control of CAR T Cells
Int J Mol Sci, 22 (9)
DOI 10.3390/ijms22094320, PubMed 33919245

Publications 2020

Caulier B, Stofleth G, Hannani D, Guidetti M, Josserand V, Laurin D, Chroboczek J, Mossuz P, Plantaz D (2020)
Evaluation of the human type 3 adenoviral dodecahedron as a vector to target acute myeloid leukemia
Mol Ther Methods Clin Dev, 20, 181-190
DOI 10.1016/j.omtm.2020.11.009, PubMed 33473357

Publications 2017

Caulier B, Berthoin L, Coradin H, Garban F, Dagher MC, Polack B, Toussaint B, Lenormand JL, Laurin D (2017)
Targeted release of transcription factors for human cell reprogramming by ZEBRA cell-penetrating peptide
Int J Pharm, 529 (1-2), 65-74
DOI 10.1016/j.ijpharm.2017.06.073, PubMed 28647433

Publications 2016

Berthoin L, Toussaint B, Garban F, Le Gouellec A, Caulier B, Polack B, Laurin D (2016)
Targeted release of transcription factors for cell reprogramming by a natural micro-syringe
Int J Pharm, 513 (1-2), 678-687
DOI 10.1016/j.ijpharm.2016.09.081, PubMed 27697633

Page visits: 3051